PCN20 COST-EFFECTIVENESS ASSESSMENT FOR COLOMBIA OF LETROZOLE VS. TAMOXIFEN IN ADJUVANT TREATMENT OF HORMONE RECEPTOR-POSITIVE, POST-MENOPAUSAL EARLY BREAST CANCER WOMEN
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75347-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)75347-X/fulltext
Title :
PCN20 COST-EFFECTIVENESS ASSESSMENT FOR COLOMBIA OF LETROZOLE VS. TAMOXIFEN IN ADJUVANT TREATMENT OF HORMONE RECEPTOR-POSITIVE, POST-MENOPAUSAL EARLY BREAST CANCER WOMEN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75347-X&doi=10.1016/S1098-3015(10)75347-X
First page :
Section Title :
Open access? :
No
Section Order :
1273